The Lead Episode 90: A Discussion of Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia

Discussion Topic: Vasovagal Responses to Human Monomorphic Ventricular Tachycardia Hemodynamic Implications From Sinus Rate Analysis

William H. Sauer, MD, FHRS, CCDS, Brigham and Women’s Hospital is joined by Isabella Alviz, MD, Brigham, and Women’s Hospital, and Usha B. Tedrow, MD, MS, FHRS, Brigham and Women’s Hospital to discuss how patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular tachycardia. Whether catheter ablation is more effective than antiarrhythmic drugs as a first-line therapy in patients with ventricular tachycardia is uncertain.

Host: William H. Sauer, MD, FHRS, CCDS
Guests: Isabella Alviz, MD and Usha B. Tedrow, MD, MS, FHRS

Speaker and Article Information: Download

• Listen on HRS365
• Listen on Apple Podcasts
• Listen on Spotify
• Listen on iHeart